ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

MRUS Merus NV

44.91
-0.20 (-0.44%)
After Hours
Last Updated: 08:04:29
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Merus NV MRUS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.20 -0.44% 44.91 08:04:29
Open Price Low Price High Price Close Price Previous Close
45.16 44.38 46.1912 44.91 45.11
more quote information »

Recent News

Date Time Source Heading
09/4/202402:00GLOBEMerus Presents Preclinical Data Demonstrating Efficacy of..
03/4/202423:00GLOBEMerus to Participate in a Fireside Chat at the 23rd Annual..
07/3/202400:15EDGAR2Form 8-K - Current report
07/3/202400:00BWGilead and Merus Announce Collaboration to Discover Novel..
06/3/202408:30GLOBEMerus Announces Publication of an Abstract for Presentation..
05/3/202400:00GLOBEMerus to Participate in a Fireside Chat at the Leerink..
29/2/202408:55EDGAR2Form S-3ASR - Automatic shelf registration statement of..
29/2/202408:15GLOBEMerus Announces Financial Results for the Fourth Quarter and..
15/2/202408:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202400:00GLOBEMerus to Participate in Upcoming Investor Conferences
21/12/202308:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202309:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202311:29EDGAR2Form 144 - Report of proposed sale of securities
13/12/202308:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202308:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/12/202312:40GLOBEMerus Presents Interim Data on MCLA-129 at ESMO Asia..
02/12/202302:47EDGAR2Form 144 - Report of proposed sale of securities
27/11/202303:05GLOBEMerus Announces Publication of Abstracts on MCLA-129 for..
03/11/202307:12GLOBEMerus Announces Financial Results for the Third Quarter 2023..
03/11/202307:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202323:00GLOBEMerus to Participate in Upcoming Investor Conferences
23/10/202322:30GLOBEMerus’ Zeno Interim Data Continues to Demonstrate Robust and..
16/10/202310:58GLOBEMerus Announces Business Update Conference Call
12/10/202307:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202307:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/10/202300:32GLOBEMerus Announces Abstracts Accepted for Presentation at the..
31/8/202322:00GLOBEMerus to Participate in Upcoming Investor Conferences
12/8/202306:01EDGAR2Form 8-K - Current report
11/8/202323:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/8/202311:53GLOBEMerus Announces Pricing of Public Offering of Common Shares
10/8/202306:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/8/202306:01GLOBEMerus N.V. Announces Proposed Public Offering of Common..
08/8/202306:26GLOBEMerus Announces Financial Results for the Second Quarter..
08/8/202306:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
28/7/202322:00GLOBEMerus Announces Two Clinical Abstracts on Zenocutuzumab..
06/7/202306:01GLOBEZenocutuzumab (Zeno) granted second Breakthrough Therapy..
30/6/202306:30GLOBEZenocutuzumab (Zeno) granted Breakthrough Therapy..
15/6/202321:47GLOBEMerus Appoints Life Sciences Strategic and Financial..
31/5/202322:00GLOBEMerus to Participate in a Fireside Chat at the Jefferies..
05/5/202306:25GLOBEMerus Announces Financial Results for the First Quarter 2023..

Your Recent History

Delayed Upgrade Clock